Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
Gastrointestinal Issues Like semaglutide, tirzepatide can cause nausea, heart burn, vomiting, diarrhea, and constipation
Women with a personal or family history of thyroid cancer or gallbladder disease should be especially cautious. The FDA warning regarding a history of thyroid cancer applies specifically to the rare medullary or C-cell form, which can be part of Multiple Endocrine Neoplasia type 2 syndrome
(August 1945)
They may be a good option if you want a quick visit without a full IV drip
Your brain reads the drops as the GLP-1 hormone, which allows vital hormonal changes to happen
US$ 24.41
US$ 21.10
US$ 26.63
US$ 22.83
US$ 25.99
